SG11201704143YA - Pharmaceutical composition, preparation and uses thereof - Google Patents

Pharmaceutical composition, preparation and uses thereof

Info

Publication number
SG11201704143YA
SG11201704143YA SG11201704143YA SG11201704143YA SG11201704143YA SG 11201704143Y A SG11201704143Y A SG 11201704143YA SG 11201704143Y A SG11201704143Y A SG 11201704143YA SG 11201704143Y A SG11201704143Y A SG 11201704143YA SG 11201704143Y A SG11201704143Y A SG 11201704143YA
Authority
SG
Singapore
Prior art keywords
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SG11201704143YA
Inventor
Marie-Edith Meyre
Agnès Pottier
Laurent Levy
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of SG11201704143YA publication Critical patent/SG11201704143YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201704143YA 2014-11-25 2015-11-24 Pharmaceutical composition, preparation and uses thereof SG11201704143YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306873 2014-11-25
PCT/EP2015/077438 WO2016083336A1 (en) 2014-11-25 2015-11-24 Pharmaceutical composition, preparation and uses thereof

Publications (1)

Publication Number Publication Date
SG11201704143YA true SG11201704143YA (en) 2017-06-29

Family

ID=52013980

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704143YA SG11201704143YA (en) 2014-11-25 2015-11-24 Pharmaceutical composition, preparation and uses thereof

Country Status (16)

Country Link
US (1) US20170258718A1 (en)
EP (1) EP3229781A1 (en)
JP (1) JP2018500298A (en)
KR (1) KR20170086638A (en)
CN (1) CN107106505A (en)
AR (1) AR102779A1 (en)
AU (1) AU2015352688A1 (en)
BR (1) BR112017010933A2 (en)
CA (1) CA2968473A1 (en)
EA (1) EA201791138A1 (en)
HK (1) HK1245086A1 (en)
IL (1) IL252397A0 (en)
MX (1) MX2017006813A (en)
SG (1) SG11201704143YA (en)
TW (1) TW201628639A (en)
WO (1) WO2016083336A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6387400B2 (en) 2013-05-30 2018-09-05 ナノビオティックスＮａｎｏｂｉｏｔｉｘ Pharmaceutical composition, its manufacture and use
HUE062561T2 (en) 2014-11-25 2023-11-28 Curadigm Sas Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof
NZ769187A (en) 2014-11-25 2023-07-28 Curadigm Sas Pharmaceutical composition, preparation and uses thereof
PT3223796T (en) 2014-11-25 2021-09-28 Curadigm Sas Pharmaceutical compositions, preparation and uses thereof
TW201628644A (en) 2014-11-25 2016-08-16 奈諾生技公司 Pharmaceutical composition, preparation and uses thereof
WO2016189125A1 (en) 2015-05-28 2016-12-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine
KR20200110321A (en) * 2017-12-19 2020-09-23 나노비오띡스 Nanoparticles for use in the treatment of neurological disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1701745B1 (en) 2003-12-22 2014-12-10 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
WO2005086639A2 (en) 2004-02-10 2005-09-22 Barnes-Jewish Hospital Improved efficacy and safety of targeted particulate agents with decoy systems
US20090130050A1 (en) * 2006-03-24 2009-05-21 Toto Ltd. Titanium Oxide Composite Particles, Dispersion Liquid Thereof, and Process for Producing Them
EP1852107A1 (en) 2006-04-19 2007-11-07 Nanobiotix Magnetic nanoparticles compositions and uses thereof
EP2130553A1 (en) 2008-06-05 2009-12-09 Nanobiotix Inorganic nanoparticles of high density to destroy cells in-vivo
JP2014503575A (en) * 2011-01-31 2014-02-13 ナノビオティックス Method for monitoring release of products of interest from liposomes using superparamagnetic nanoparticles
PL2670394T3 (en) * 2011-01-31 2019-03-29 Nanobiotix Nanoparticles delivery systems, preparation and uses thereof
ITRM20120480A1 (en) * 2012-10-09 2014-04-10 Uni Degli Studi Camerino MULTICOMPONENT LIPID NANOPARTICLES AND PROCEDURES FOR THEIR PREPARATION.

Also Published As

Publication number Publication date
CN107106505A (en) 2017-08-29
TW201628639A (en) 2016-08-16
MX2017006813A (en) 2018-01-30
IL252397A0 (en) 2017-07-31
HK1245086A1 (en) 2018-08-24
WO2016083336A1 (en) 2016-06-02
JP2018500298A (en) 2018-01-11
KR20170086638A (en) 2017-07-26
EA201791138A1 (en) 2017-09-29
AU2015352688A1 (en) 2017-07-13
AR102779A1 (en) 2017-03-22
CA2968473A1 (en) 2016-06-02
BR112017010933A2 (en) 2018-02-14
US20170258718A1 (en) 2017-09-14
EP3229781A1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
IL276695B (en) Antibodies, pharmaceutical compositions and uses thereof
GB201409471D0 (en) Pharmaceutical composition
HK1232169A1 (en) Substituted 4-phenylpiperidines, their preparation and use 4-
LT3223796T (en) Pharmaceutical compositions, preparation and uses thereof
IL252397A0 (en) Pharmaceutical composition, preparation and uses thereof
GB201409488D0 (en) Pharmaceutical composition
IL290114A (en) Pharmaceutical composition, preparation and uses thereof
GB201409485D0 (en) Pharmaceutical composition
ZA201703398B (en) Pharmaceutical composition and methods
PL3229843T3 (en) Pharmaceutical composition, preparation and uses thereof
HK1214767A1 (en) Tablet-formed pharmaceutical composition and preparation method thereof
ZA201502073B (en) Pharmaceutical composition
IL262929A (en) Composition, and application and pharmaceutical preparation thereof
ZA201508726B (en) Pharmaceutical composition
HUE050881T2 (en) Pharmaceutical composition
GB2509426B (en) Clomazone composition, its preparation and use thereof
SG10201504332VA (en) Pharmaceutical Composition
IL249073B (en) Chitin-glucan complex, its preparation, and uses
TH1501007100A (en) Pharmaceutical composition, preparation and its uses